In drug development, understanding the metabolic profile of a drug is essential for predicting its safety and efficacy. Metabolites are studied during preclinical and clinical trials to ensure that they do not pose significant risks. Regulatory agencies, such as the FDA, often require detailed information on the metabolites of new drugs before approval.
